secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2022-08-25T23:59:59+00:00
Accession:  0001140361-22-030901
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen expands Burleson facility and amends tissue processing agreement
-----------------------------------------------------------------------

- First Amendment to Burleson lease doubles space to 5,000 sq ft, extends term to September 2027.
- Monthly base rent starts at $4,583 (Oct 2022) and increases to $5,464 (Oct 2026-2027).
- Eighth Amendment to License and Services Agreement with Community Blood Center updates termination notice and decommission duties.
- Processing fees set: $300.48 per nerve tissue debridement batch, $1,120.04 per nerve processing batch, $150 birth tissue debridement, $1,500 birth tissue processing.
- Licensor will provide cleaning/sterilization services for product processed at Licensee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000114036122030901/0001140361-22-030901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000114036122030901/brhc10041274_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-030901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer